| 摘要 |
It is intended to provide a novel means for a novel immunotherapy under paying attention to the effects of activating NK cells, activating NKT cells, inhibiting angiogenesis, inducing IL-12 production and inducing IFNgamma production. More specifically speaking, a novel use of immunotherapeutics for cancer characterized by comprising, to treat cancer depending on tissue and/or tissue type, classifying the treatment mechanisms at least into: 1 an effect of inhibiting angiogenesis 2 an effect of inducing Th1 cytokines TNFalpha, IFNgamma and IL-12 and activating CTL 3 increasing NK cells or activating the same and 4 increasing NKT cells or activating the same, then measuring markers corresponding to respective effects, analyzing the measurement data depending on cancer tissue and/or tissue type, and thus selecting a prescription appropriate for the cancer tissue and/or tissue type.
|
